Residency · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
JAMA oncology · 2022 · 1,677 citations · Sara Sheikhbahaei
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
European journal of nuclear medicine and molecular imaging · 2023 · 338 citations · Steve Cho, Heather Jacene, Charles Marcus, Steven Rowe
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.
JAMA neurology · 2021 · 503 citations · Sara Sheikhbahaei
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).
European urology · 2023 · 242 citations · Steven Rowe, Andrei Gafita
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 84 citations · Steve Cho
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2023 · 189 citations · Anthony Fotenos
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
European journal of nuclear medicine and molecular imaging · 2021 · 302 citations · Steven Rowe
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
The Journal of urology · 2021 · 322 citations · Steven Rowe